Latest Zealand Pharma News & Updates

See the latest news and media coverage for Zealand Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Zealand Pharma

Biotechnology company focused on metabolic health medicines

zealandpharma.com

Headquarters: Søborg (Copenhagen), Denmark
Founded year: 1998
Company type: Public company
Number of employees: 200–700
Industry: Pharmaceuticals

Last updated Today

Latest news about Zealand Pharma

In short: Zealand Pharma advanced its obesity drug pipeline and launched a USD 200 million share buy-back program following strong 2025 results.

Company announcements

July 20 Zealand Pharma

Zealand Pharma reports share buy-back transactions for week 30, 2026

The company repurchased 198,000 shares at an average price of approximately DKK 295 per share.

June 30 Zealand Pharma

Zealand Pharma announces total shares and voting rights

The company provides the figures following a share capital increase from employee warrant exercises.

June 7 Zealand Pharma

Zealand Pharma announces survodutide trial reducing visceral and liver fat

Results also showed 63% liver fat reduction and minimized lean mass loss, supporting metabolic health improvement.

June 5 Zealand Pharma

Zealand Pharma reports positive Phase 2 petrelintide data

The ZUPREME-1 trial showed double-digit weight loss and placebo-like tolerability at 42 weeks, supporting Phase 3 plans for second half of 2026.

Media coverage

July 23 Euroinvestor

Roche exceeds expectations - good news for Zealand Pharma

The Swiss pharmaceutical giant Roche has had a strong first half. The underlying business grows by 6%, Roche reports in the financial statement, which...

July 14 Investing.com

Zealand Pharma shares slide as Jefferies cuts to Hold, slashes price target 37% By Investing.com

Zealand Pharma shares slide as Jefferies cuts to Hold, slashes price target 37...

July 13 Euroinvestor

Major bank lowers recommendation for Zealand Pharma stock

Major bank Jefferies is not entirely satisfied with the Danish biotech company Zealand Pharma. This causes the bank to lower its recommendation to hold from previous buy...

July 8 Yahoo Finance

Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value

Zealand Pharma stock has delivered a 62.9% gain over the past five years, yet the current checks suggest the shares lean ...

Never miss news about Zealand Pharma

Track Zealand Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Zealand Pharma competitors & trending companies

Browse news for competitors to Zealand Pharma and other trending companies.